✦ LIBER ✦

FGFR3 and TP53 gene mutations define distinct pathways at initial diagnosis in urothelial cell carcinomas of the bladder

✍ Scribed by Dominique K Chopin; Ashraf A Bakkar; Herve Wallerand; François Radvanyi; Jean-baptiste Lahey; Serge Pissard; Laure Lecerf; Jean Claude Kouyoumdjian; Claude C Abbou; Jean-Claude Pairon; Marie-Claude Jaurand; Jean-Paul Thiery; Sixtina Gil Diez de Medina

Book ID: 118645146
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 91 KB
Volume: 2
Category: Article
ISSN: 1569-9056
DOI: 10.1016/s1569-9056(03)90513-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

7159 POSTER Mutations in FGFR3 and Ras i

7159 POSTER Mutations in FGFR3 and Ras in Urothelial Cell Carcinomas of the Bladder – No Association With MAPK Pathway Activation

✍ Hernandez, S.; Juanpere, N.; Agell, L.; Lorenzo, M.; De Muga, S.; Serrano, S.; L 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 42 KB

422 PROGNOSTIC VALUE OF ABNORMAL HYPERME

422 PROGNOSTIC VALUE OF ABNORMAL HYPERMETHYLATION OF P16 GENE PROMOTER, 3P-DELETION, MUTATION IN FGFR3 GENE AND LOH P53 GENE IN UROTHELIAL CARCINOMA CELLS NON-MUSCLE INVASIVE BLADDER CANCER

✍ S. Bashkatov; O.B. Karyakin; M.V. Nemtsova; A.Y. Babayan 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 504 KB